On November 15, 2017, Imagia Cybernetics Inc. (“Imagia”) announced the completion of its acquisition of Cadens Medical Imaging (“Cadens”).
This strategic transaction will significantly accelerate Imagia’s mission of delivering accessible personalized healthcare solutions that are driven by artificial intelligence (“AI”).
Cadens is a technology leader in medical imaging software that has extensive experience in delivering patient benefits through AI-based software products.
Imagia is a Montreal-based healthcare AI company that develops radiomics biomarkers and clinical decision support systems.
Osler, Hoskin & Harcourt LLP represented Imagia with a team consisting of Nathalie Beauregard and Tim Apedaile (Corporate), Alain Fournier (Tax), Lee Webster (Intellectual Property), and Sven Poysa (Employment and Labour).
Key Contact
Partner, Emerging and High Growth Companies, Montréal
